Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer
J. Clin. Invest. Jeffrey A. Engelman, et al. 116:2695 doi:10.1172/JCI28656 [Go to this article.]

Table 1
Summary of parental and engineered cell lines